Related references
Note: Only part of the references are listed.Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review
Amanda S. S. Nitschke et al.
CANCERS (2023)
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers
Ruta Marcinkute et al.
JOURNAL OF MEDICAL GENETICS (2022)
Scar-Free Laparoscopy in BRCA-Mutated Women
Stefano Restaino et al.
MEDICINA-LITHUANIA (2022)
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial
Faiza Gaba et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Bilateral Salpingo-Oophorectomy to Reduce Breast Cancer Risk in Women With Germline BRCA1 or BRCA2 Pathogenic Variants-Caution Needed Reply
Yun-Hee Choi et al.
JAMA ONCOLOGY (2021)
Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers
Faiza Gaba et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
Jack Cuzick et al.
LANCET (2020)
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
Nasim Mavaddat et al.
BREAST CANCER RESEARCH (2020)
Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
Mary Beth Terry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Bernadette A. M. Heemskerk-Gerritsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Medication Use for the Risk Reduction of Primary Breast Cancer in Women Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Heidi D. Nelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review
Ye-Lei Xiao et al.
CLINICAL BREAST CANCER (2019)
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations
Denise R. Nebgen et al.
GYNECOLOGIC ONCOLOGY (2018)
Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers
Marta D'Alonzo et al.
CLINICAL BREAST CANCER (2018)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study
Phuong L. Mai et al.
GYNECOLOGIC ONCOLOGY (2017)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
Ingrid E. Fakkert et al.
PLOS ONE (2017)
Racial Disparities in BRCA Testing and Cancer Risk Management Across a Population-Based Sample of Young Breast Cancer Survivors
Deborah Cragun et al.
CANCER (2017)
Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature
Teresa Flippo-Morton et al.
BREAST JOURNAL (2016)
Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea
Se Ik Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
Janusz Menkiszak et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer
Ingrid E. Fakkert et al.
EUROPEAN JOURNAL OF CANCER (2015)
Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis
N. N. Basu et al.
FAMILIAL CANCER (2015)
Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
Christine Garcia et al.
GYNECOLOGIC ONCOLOGY (2015)
Properties of the quantity disagreement and the allocation disagreement
Matthijs J. Warrens
INTERNATIONAL JOURNAL OF REMOTE SENSING (2015)
Untitled RESPONSE
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis
Luz Viale et al.
LANCET (2015)
Untitled RESPONSE
B. A. M. Heemskerk-Gerritsen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Kelly Metcalfe et al.
JAMA ONCOLOGY (2015)
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis
Antonis Valachis et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers
Xinglei Chai et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers
Laura L. Holman et al.
GYNECOLOGIC ONCOLOGY (2014)
The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers.
Kelly A. Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer
D. Gareth R. Evans et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Does postmenopausal risk-reducing salpingo-oophorectomy reduce the risk of BRCA-associated breast cancer?
J. Barlin et al.
GYNECOLOGIC ONCOLOGY (2013)
Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer
Tomasz Huzarski et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick et al.
LANCET (2013)
Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study
William H. Parker et al.
OBSTETRICS AND GYNECOLOGY (2013)
Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance
Marc D. Schwartz et al.
CANCER (2012)
Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Joanne Kotsopoulos et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause
Carmel Pezaro et al.
FAMILIAL CANCER (2012)
Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers
Brian S. Finkelman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status
R. Manchanda et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
Kelly Metcalfe et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K. Metcalfe et al.
BRITISH JOURNAL OF CANCER (2011)
Satisfaction With Ovarian Carcinoma Risk-Reduction Strategies Among Women at High Risk for Breast and Ovarian Carcinoma
Shannon N. Westin et al.
CANCER (2011)
GRADE guidelines: 7. Rating the quality of evidence-inconsistency
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing*
A-B Skytte et al.
CLINICAL GENETICS (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Choice of Management of Southern Chinese BRCA Mutation Carriers
Ava Kwong et al.
WORLD JOURNAL OF SURGERY (2010)
Uptake of Risk-Reducing Surgery in Unaffected Women at High Risk of Breast and Ovarian Cancer Is Risk, Age, and Time Dependent
D. Gareth R. Evans et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers
Mary S. Beattie et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Increased cardiovascular mortality after early bilateral oophorectomy
Cathleen M. Rivera et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting:: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
D. Gareth Evans et al.
BMC CANCER (2008)
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
Angela R. Bradbury et al.
GENETICS IN MEDICINE (2008)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer:: A multicenter, prospective study
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Increased risk of parkinsonism in women who underwent oophorectomy before menopause
W. A. Rocca et al.
NEUROLOGY (2008)
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers
Tara M. Friebel et al.
CLINICAL BREAST CANCER (2007)
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause
W. A. Rocca et al.
NEUROLOGY (2007)
Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer
U. Menon et al.
HUMAN REPRODUCTION (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Age at menarche and menopause and breast cancer risk in the international BRCA1/2 Carrier Cohort Study
Jenny Chang-Claude et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing -: A single-institution study
Anne Uyei et al.
CANCER (2006)
Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing
Vardit Kram et al.
FAMILIAL CANCER (2006)
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study
Walter A. Rocca et al.
LANCET ONCOLOGY (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
Amy Finch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis
F Atsma et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2006)
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
SM Domchek et al.
LANCET ONCOLOGY (2006)
Survival and prognostic factors in BRCA1-associated breast cancer
CTM Brekelmans et al.
ANNALS OF ONCOLOGY (2006)
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers
JL Kramer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer risk following bilateral oophorectorny in BRCA1 and BRCA2 mutation carriers:: An international case-control study
A Eisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer
JB Madalinska et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
TC van Sprundel et al.
BRITISH JOURNAL OF CANCER (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women
JFR Robertson et al.
EUROPEAN JOURNAL OF CANCER (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Genetic testing for a BRCA1 mutation:: Prophylactic surgery and screening behavior in women 2 years post testing
JR Botkin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: A prospective study
K Tiller et al.
GYNECOLOGIC ONCOLOGY (2002)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (Surveillance or prophylactic surgery)
LN Lodder et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling
KA Metcalfe et al.
JOURNAL OF MEDICAL GENETICS (2000)
Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing
C Lerman et al.
PREVENTIVE MEDICINE (2000)
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
EJ Meijers-Heijboer et al.
LANCET (2000)
Share Paper
